MIP-1a has not been widely used for diagnostic purposes, apart from malignant gliomas, in which MIP-1a levels provided 100 % sensitivity and 88 % specificity for the diagnosis of this tumor type versus controls [51]. This evidence concerns the gene CCL3 and neoplasm.